Testing effectiveness (Phase 2)Ended earlyNCT02059252
What this trial is testing
Safety, Tolerability and Performance of SmartMatrix Dermal Replacement Scaffold
Who this might be right for
Basal Cell CarcinomaSquamous Cell Carcinoma
Smart Matrix Limited 5